Skip to main content
OpenTrials

Clinical trial condition

HER2/Neu Negative

Explore clinical trials studying HER2/Neu Negative. Study availability and eligibility vary by location and protocol.

55 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

HER2/Neu Negative trial results

Recruiting

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

NCT03723928

Conditions
Anatomic Stage IV Breast Cancer AJCC v8, Elevated CA15-3 or CEA or CA27-29, Estrogen Receptor Positive, +3 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 723 locations
View Trial Details
Recruiting

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

NCT02945579

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +16 more
Locations
  • MD Anderson Cancer Center - Banner Gilbert, Arizona, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
  • Queen's Medical Center Honolulu, Hawaii, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, not recruiting

Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic

NCT02115282

Conditions
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Adenocarcinoma, +10 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • Mercy San Juan Medical Center Carmichael, California, United States
  • Enloe Medical Center Chico, California, United States
View all 653 locations
View Trial Details
Active, not recruiting

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

NCT02445391

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +16 more
Locations
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 1024 locations
View Trial Details
Active, not recruiting

Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca

NCT02957968

Conditions
Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +17 more
Locations
  • St. Elizabeth Healthcare Edgewood, Kentucky, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • University of Virginia Charlottesville, Virginia, United States
  • Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States
View Trial Details
Active, not recruiting

FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy

NCT02398773

Conditions
HER2/Neu Negative, Progesterone Receptor Negative, Progesterone Receptor Positive, +1 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 25 locations
View Trial Details

Related conditions